These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 35612311)

  • 1. Tuberculosis Drug Discovery: Challenges and New Horizons.
    Fernandes GFS; Thompson AM; Castagnolo D; Denny WA; Dos Santos JL
    J Med Chem; 2022 Jun; 65(11):7489-7531. PubMed ID: 35612311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key challenges in TB drug discovery: A perspective.
    Shaik BB; Karpoormath R
    Bioorg Med Chem Lett; 2024 Sep; 109():129846. PubMed ID: 38857850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenolic Compounds as Promising Drug Candidates in Tuberculosis Therapy.
    Mazlun MH; Sabran SF; Mohamed M; Abu Bakar MF; Abdullah Z
    Molecules; 2019 Jul; 24(13):. PubMed ID: 31277371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery.
    de Wet TJ; Warner DF; Mizrahi V
    Acc Chem Res; 2019 Aug; 52(8):2340-2348. PubMed ID: 31361123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunities and challenges of using five-membered ring compounds as promising antitubercular agents.
    Yan M; Xu L; Wang Y; Wan J; Liu T; Liu W; Wan Y; Zhang B; Wang R; Li Q
    Drug Dev Res; 2020 Jun; 81(4):402-418. PubMed ID: 31904877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SAR analysis of new anti-TB drugs currently in pre-clinical and clinical development.
    Poce G; Cocozza M; Consalvi S; Biava M
    Eur J Med Chem; 2014 Oct; 86():335-51. PubMed ID: 25173852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New perspectives on the treatment of mycobacterial infections using antibiotics.
    He Y; Fan A; Han M; Zhang Y; Tong Y; Zheng G; Zhu S
    Appl Microbiol Biotechnol; 2020 May; 104(10):4197-4209. PubMed ID: 32185432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Affairs, Future Perspectives of Tuberculosis and Antitubercular Agents.
    Gawad J; Bonde C
    Indian J Tuberc; 2018 Jan; 65(1):15-22. PubMed ID: 29332642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The quest for the holy grail: new antitubercular chemical entities, targets and strategies.
    Huszár S; Chibale K; Singh V
    Drug Discov Today; 2020 Apr; 25(4):772-780. PubMed ID: 32062007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis: current treatment, diagnostics, and newer antitubercular agents in clinical trials.
    Ahsan MJ; Ansari MY; Yasmin S; Jadav SS; Kumar P; Garg SK; Aseri A; Khalilullah H
    Infect Disord Drug Targets; 2015; 15(1):32-41. PubMed ID: 25246035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bottlenecks and opportunities in antibiotic discovery against Mycobacterium tuberculosis.
    Craggs PD; de Carvalho LPS
    Curr Opin Microbiol; 2022 Oct; 69():102191. PubMed ID: 35970040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening.
    Manjunatha UH; Smith PW
    Bioorg Med Chem; 2015 Aug; 23(16):5087-97. PubMed ID: 25577708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent updates on drug resistance in Mycobacterium tuberculosis.
    Singh R; Dwivedi SP; Gaharwar US; Meena R; Rajamani P; Prasad T
    J Appl Microbiol; 2020 Jun; 128(6):1547-1567. PubMed ID: 31595643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the tuberculosis drug development pipeline.
    Evangelopoulos D; McHugh TD
    Chem Biol Drug Des; 2015 Nov; 86(5):951-60. PubMed ID: 25772393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy Induction as a Host-Directed Therapeutic Strategy against
    Adikesavalu H; Gopalaswamy R; Kumar A; Ranganathan UD; Shanmugam S
    Medicina (Kaunas); 2021 May; 57(6):. PubMed ID: 34070995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promising drugs against tuberculosis.
    de Souza MV
    Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):33-44. PubMed ID: 18221132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug targets exploited in Mycobacterium tuberculosis: Pitfalls and promises on the horizon.
    Bhat ZS; Rather MA; Maqbool M; Ahmad Z
    Biomed Pharmacother; 2018 Jul; 103():1733-1747. PubMed ID: 29864964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.